Ethanol Lock Therapy for Treatment and Secondary Prophylaxis of Central Line-Associated Bloodstream Infection

NCT01472965 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Central Line-Associated Bloodstream Infection

Interventions

DRUG: ethanol
DRUG: heparin-saline placebo

Sponsor

St. Jude Children's Research Hospital